COMPARISON OF INFLIXIMAB AND USTEKIMUMAB FOR TREATMENT OF MODERATE TO SEVERE PSORIASIS: A MIXED TREATMENT META-ANALYSIS

被引：0
|
作者：
Fan, T. [1 ]
Bennett, H. [2 ]
Smith, N. [1 ]
Marin, M. [2 ]
Sen, S. [1 ]
机构：
[1] Merck & Co Inc, Whitehouse Stn, NJ USA
[2] OptumInsight, Burlington, ON, Canada
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.977
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A410 / A411
页数：2
相关论文
共 50 条
  • [31] Risankizumab for the treatment of moderate to severe psoriasis
    Chiricozzi, Andrea
    Antonioli, Luca
    Panduri, Salvatore
    Fornai, Matteo
    Romanelli, Marco
    Blandizzi, Corrado
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (01) : 1 - 8
  • [32] Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis
    Mills, Edward J.
    Perri, Dan
    Cooper, Curtis
    Nachega, Jean B.
    Wu, Ping
    Tleyjeh, Imad
    Phillips, Peter
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2009, 8
  • [33] Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis
    Edward J Mills
    Dan Perri
    Curtis Cooper
    Jean B Nachega
    Ping Wu
    Imad Tleyjeh
    Peter Phillips
    [J]. Annals of Clinical Microbiology and Antimicrobials, 8
  • [34] Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis
    Mills, Edward J.
    Peeri, Dan
    Cooper, Curtis
    Nachega, Jean B.
    Wu, Ping
    Tleyjeh, Imad
    Philips, Peter
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2009, 8
  • [35] Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis
    Loos, Anne M.
    Liu, Shanshan
    Segel, Celia
    Ollendorf, Daniel A.
    Pearson, Steven D.
    Linder, Jeffrey A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) : 135 - +
  • [36] TARGETED IMMUNOMODULATORS FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS COMPARING BINOMIAL AND MULTINOMIAL APPROACHES
    Fahim, S. M.
    Wright, A.
    Nikitin, D.
    McKenna, A.
    Agboola, F.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S279 - S279
  • [37] COMPARATIVE EFFECTIVENESS OF TARGETED IMMUNOMODULATORS FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Loos, A. M.
    Liu, S.
    Segel, C.
    Ollendorf, D.
    Pearson, S. D.
    Linder, J. A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A210 - A210
  • [38] Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
    Lucka, T. C.
    Pathirana, D.
    Sammain, A.
    Bachmann, F.
    Rosumeck, S.
    Erdmann, R.
    Schmitt, J.
    Orawa, H.
    Rzany, B.
    Nast, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (11) : 1331 - 1344
  • [39] Efficacy and safety of guselkumab for the treatment of patients with moderate-to-severe plaque psoriasis: A meta-analysis of randomized clinical trials
    Tao, Xing-Bao
    Huang, Yin-Qiu
    Zhou, Yi-Hong
    Zhang, Lv-Lang
    Chen, Yao-Kai
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (02) : 433 - 440
  • [40] Infliximab in the treatment of moderate to severe atopic dermatitis
    Jacobi, A
    ANtoni, C
    Manger, B
    Schulter, G
    Hertl, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : 522 - 526
12345